E HARZER
Overview
Explore the profile of E HARZER including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liese J, Stojanov S, Berut F, Minini P, HARZER E, Jow S, et al.
Vaccine
. 2001 Oct;
20(3-4):448-54.
PMID: 11672908
A study was conducted to assess the safety of a new, liquid hexavalent vaccine (Hexavac, Aventis Pasteur MSD, Lyon, France) in a large population of 1783 children in Germany vaccinated...
2.
Liese J, Stojanov S, Zink T, FROESCHLE J, Klepadlo R, Kronwitter A, et al.
Pediatr Infect Dis J
. 2001 Oct;
20(10):981-8.
PMID: 11642633
Objectives: To evaluate the safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid (Biken DTaP) vaccine administered to children 4 to 6 years of...
3.
Stojanov S, Liese J, Bendjenana H, HARZER E, Barrand M, Jow S, et al.
Pediatr Infect Dis J
. 2000 Jul;
19(6):516-21.
PMID: 10877165
Objective: To compare the immunogenicity and safety of a trivalent tetanus-diphtheria (low toxoid content)-inactivated poliomyelitis vaccine, Td-IPV (Revaxis; Pasteur Merièux), with a tetanus-diphtheria (low toxoid content) vaccine, Td (Td-Impfstoff Mérieux;...
4.
Laroche P, Barrand M, Wood S, Van Hasbrouck K, LANG J, HARZER E, et al.
Infection
. 1999 Apr;
27(1):49-56.
PMID: 10206791
In view of the continuing risk of contracting tetanus, diphtheria and poliomyelitis, and the well-documented decline in immunity with time, the need for booster vaccinations is substantial. The immunogenicity and...
5.
Liese J, Meschievitz C, HARZER E, FROESCHLE J, Hosbach P, Hoppe J, et al.
Pediatr Infect Dis J
. 1997 Dec;
16(11):1038-44.
PMID: 9384336
Objective: This case-control study investigated the protective efficacy against pertussis of three doses of a two-component acellular pertussis vaccine (manufactured by Biken in Japan) combined with diphtheria and tetanus toxoids...
6.
Heijbel H, Ciofi Degli Atti M, HARZER E, Liese J, Preziosi M, Rasmussen F, et al.
Dev Biol Stand
. 1997 Jan;
89:101-3.
PMID: 9272338
No abstract available.
7.